LR-103

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLR-103
Drug Alias NameLR-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdvanced glycation end product agonists
TargetsAdvanced glycation end product
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofiGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiGenzyme Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A